A Retrospective Evaluation of Pd-L1 Expression and Heterogeneity in Early-Stage Non-Small Cell Lung Cancer (Replica)
Eleni Josephides(Guy's and St Thomas' NHS Foundation Trust), Eleni Karapanagiotou(King's College London), Daniel Smith(Guy's and St Thomas' NHS Foundation Trust), Andrea Billè(King's College London), Maria Monroy-Inglesias, James Spicer(King's College London), Debra H. Josephs(Guy's and St Thomas' NHS Foundation Trust), Akshay J. Patel(NIHR Surgical Reconstruction and Microbiology Research Centre), Sarah Hunter(Guy's and St Thomas' NHS Foundation Trust), Hannah Rush(University College London), George Santis(Guy's Hospital), Annie-Rose Henry(Guy's and St Thomas' NHS Foundation Trust), Ana Montes(Guy's and St Thomas' NHS Foundation Trust), Roberta Dunn(Guy's and St Thomas' NHS Foundation Trust), Daisuke Nonaka(Guy's and St Thomas' NHS Foundation Trust), Danielle Crawley(Guy's and St Thomas' NHS Foundation Trust), Philippe Tanierre, D.J. Hughes(St Thomas' Hospital)
Cited by 0
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
|The Lancet Oncology|2021|614
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
|BORIS (University Library Bern)|2022|311